Nionyx Bio
PrivateLast Round
Seed
Sep 29, 2025
Total Funding Raised
$4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nionyx Bio operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in September 2025.
Nionyx Bio is a biotechnology company that develops AAV-based gene therapies to address kidney genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nionyx Bio Comparables
Compare Nionyx Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nephrogen | 87% | |
| Estuary Biotherapeutics | 84% | |
| Purespring Therapeutics | 80% |
For institutional investors. Book with your work email.
Nionyx Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nionyx Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Empire State Development | Seed |
| Pathway Bioventures | Seed |
| 2048 Ventures | Seed |
| New York Ventures | Seed |
| AIN Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 413% MoM, from 389 to 2K.
- Apr 21, 2026
Monthly visitors increased 2859% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
Nionyx Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nionyx Bio's valuation, stock price, and market status.
Is Nionyx Bio a public or private company?
Nionyx Bio is a private company.
What is the current stock price of Nionyx Bio?
Nionyx Bio is a private company, so its shares have no public market price. Caplight tracks Nionyx Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nionyx Bio worth (valuation)?
Valuation information for Nionyx Bio is not publicly available.
Can I buy Nionyx Bio stock?
Nionyx Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nionyx Bio's last funding round?
Nionyx Bio's most recent funding round was Seed on September 29, 2025.
Who are the main investors in Nionyx Bio?
Key investors in Nionyx Bio include 2048 Ventures.
Will Nionyx Bio IPO soon?
No public IPO plans have been announced for Nionyx Bio.
How can I track Nionyx Bio secondary market activity?
Caplight tracks bids, offers, and trades in Nionyx Bio's shares on secondary markets.